Side Effects of Drugs Annual - 1st Edition - ISBN: 9780444535504, 9780444535511

Side Effects of Drugs Annual, Volume 32

1st Edition

A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions

Editors: Jeffrey K. Aronson
Hardcover ISBN: 9780444535504
eBook ISBN: 9780444535511
Imprint: Elsevier
Published Date: 18th November 2010
Page Count: 1056
Tax/VAT will be calculated at check-out
290.00
230.00
380.00
353.00
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

  1. Central nervous system stimulants and drugs that suppress appetite
  2. Antidepressant drugs
  3. Lithium
  4. Drugs of abuse
  5. Hypnosedatives and anxiolytics
  6. Antipsychotic drugs
  7. Antiepileptic drugs
  8. Opioid analgesics and narcotic antagonists
  9. Anti-inflammatory and antipyretic analgesics and drugs used in gout
  10. General anesthetics and therapeutic gases
  11. Local anesthetics
  12. Neuromuscular blocking agents and skeletal muscle relaxants
  13. Drugs that affect autonomic functions or the extrapyramidal system
  14. Dermatological drugs, topical agents and cosmetics
  15. Antihistamines (H1 receptor antagonists)
  16. Drugs that act on the respiratory tract
  17. Positive inotropic drugs and drugs used in dysrhythmias
  18. Beta-adrenoceptor antagonists and antianginal drugs
  19. Drugs acting on the cerebral and peripheral circulations
  20. Antihypertensive drugs
  21. Diuretics
  22. Metals
  23. Metal antagonists
  24. Antiseptic drugs and disinfectants
  25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
  26. Miscellaneous antibacterial drugs
  27. Antifungal drugs
  28. Antiprotozoal Drugs
  29. Antiviral drugs
  30. Drugs used in tuberculosis and leprosy
  31. Antihelminthic drugs
  32. Vaccines
  33. Blood, blood components, plasma and plasma products
  34. Vitamins, intravenous solutions, and drugs and formulations used in nutrition
  35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis
  36. Gastrointestinal drugs
  37. Drugs that act on the immune system: cytokines and monoclonal antibodies
  38. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
  39. Corticotrophins, corticosteroids, and prostaglandins
  40. Sex hormones and related compounds, including hormonal contraceptives
  41. Thyroid hormones, iodine, and antithyroid drugs
  42. Insulin, other hypoglycemic drugs, and glucagon
  43. Miscellaneous hormones
  44. Drugs that affect lipid metabolism
  45. Cytostatic and cytotoxic drugs
  46. Radiological contrast agents
  47. Drugs used in ocular treatment
  48. Treatments used in complementary and alternative medicine
  49. Miscellaneous drugs, materials, medical devices and techniques
  50. Medication errors

Description

  1. Central nervous system stimulants and drugs that suppress appetite
  2. Antidepressant drugs
  3. Lithium
  4. Drugs of abuse
  5. Hypnosedatives and anxiolytics
  6. Antipsychotic drugs
  7. Antiepileptic drugs
  8. Opioid analgesics and narcotic antagonists
  9. Anti-inflammatory and antipyretic analgesics and drugs used in gout
  10. General anesthetics and therapeutic gases
  11. Local anesthetics
  12. Neuromuscular blocking agents and skeletal muscle relaxants
  13. Drugs that affect autonomic functions or the extrapyramidal system
  14. Dermatological drugs, topical agents and cosmetics
  15. Antihistamines (H1 receptor antagonists)
  16. Drugs that act on the respiratory tract
  17. Positive inotropic drugs and drugs used in dysrhythmias
  18. Beta-adrenoceptor antagonists and antianginal drugs
  19. Drugs acting on the cerebral and peripheral circulations
  20. Antihypertensive drugs
  21. Diuretics
  22. Metals
  23. Metal antagonists
  24. Antiseptic drugs and disinfectants
  25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
  26. Miscellaneous antibacterial drugs
  27. Antifungal drugs
  28. Antiprotozoal Drugs
  29. Antiviral drugs
  30. Drugs used in tuberculosis and leprosy
  31. Antihelminthic drugs
  32. Vaccines
  33. Blood, blood components, plasma and plasma products
  34. Vitamins, intravenous solutions, and drugs and formulations used in nutrition
  35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis
  36. Gastrointestinal drugs
  37. Drugs that act on the immune system: cytokines and monoclonal antibodies
  38. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
  39. Corticotrophins, corticosteroids, and prostaglandins
  40. Sex hormones and related compounds, including hormonal contraceptives
  41. Thyroid hormones, iodine, and antithyroid drugs
  42. Insulin, other hypoglycemic drugs, and glucagon
  43. Miscellaneous hormones
  44. Drugs that affect lipid metabolism
  45. Cytostatic and cytotoxic drugs
  46. Radiological contrast agents
  47. Drugs used in ocular treatment
  48. Treatments used in complementary and alternative medicine
  49. Miscellaneous drugs, materials, medical devices and techniques
  50. Medication errors

Key Features

  • Provides a critical yearly survey of new data and trends
  • Special reviews in this Annual include, among other topics, Epidemiology of the use of ecstasy, Paracetamol and the risk of asthma, Combination vaccines/multiple immunizations, Interactions of herbal medicines with warfarin, and Tyrosine kinase inhibitors

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries


Details

No. of pages:
1056
Language:
English
Copyright:
© Elsevier 2010
Published:
Imprint:
Elsevier
eBook ISBN:
9780444535511
Hardcover ISBN:
9780444535504

About the Editors

Jeffrey K. Aronson Editor

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.

Affiliations and Expertise

Department of Primary Health Care, University of Oxford, Oxford, UK